Astera Labs (ALAB) Director Manuel Alba Sells Shares

What Happened

• Manuel Alba, a director of Astera Labs, sold a total of 37,535 shares on July 1, 2026 in multiple open-market transactions for aggregate proceeds of approximately $16,792,741. Individual sale lots ranged from 343 to 6,630 shares at prices between about $429.58 and $468.00. The sales were reported as disposals (S) and were executed automatically under a Rule 10b5-1 trading plan.

Key Details

• Transaction date: July 1, 2026 (filed on July 6, 2026).
• Total shares sold: 37,535; total proceeds: ~$16.79 million.
• Price range across lots (per this filing): roughly $429.58 to $468.00; several lots reported as weighted-average prices with supporting footnotes.
• Plan/authority: Sales occurred pursuant to a Rule 10b5-1 plan adopted May 29, 2025 (Footnote F1).
• Ownership disclosures: Some shares sold are held by related entities/trusts (Casa Alameda 2007, LLC; Alba 2003 Living Trust) and the reporting person disclaims beneficial ownership for those holdings (Footnotes F12, F3).
• Shares owned after the transactions: Not specified in this part of the filing.
• Filing/timeliness: Form 4 filed July 6, 2026 reporting July 1 trades; this exceeds the typical two-business-day SEC reporting window and may be late. This filing is labeled Part 2 of 3.

Context

• These were sales (routine liquidity) executed under a pre-established 10b5-1 plan; such planned sales are generally treated as automatic rather than directional signals of the insider’s view. Footnotes note weighted-average prices for several grouped lots and offer to provide per-price breakdowns on request. For a complete picture (holdings after the trades and any additional related transactions), review the full Form 4 filing (all parts).